Back to Sectors

Healthcare

1 S&P 500 stocks · AI-analyzed news and insights

Today's Change

+0%

AI Sentiment

56%
Sector AnalysisLive data

Healthcare Sector Outlook

The Healthcare sector is up 0% today with neutral sentiment across 5 recent news articles. Top movers include $HOLX (+0.00%).

Bullish Factors

  • No strong bullish signals detected

Risk Factors

  • No strong bearish signals detected

Stocks in Healthcare

1 stocks
SymbolCompanyChange
$HOLXHologic Inc.+0.00%

Healthcare News

716 articles
InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
GlobeNewswire Inc.53d ago

InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics

$MRK
AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec
GlobeNewswire Inc.54d ago

AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec

$ABBV
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
GlobeNewswire Inc.54d ago

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

$ABBV
Cigna Raises Outlook, Flags Individual Exchange Exit And Strategic Review Of eviCore
Benzinga54d ago

Cigna Raises Outlook, Flags Individual Exchange Exit And Strategic Review Of eviCore

$CI
BSX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX
GlobeNewswire Inc.55d ago

BSX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX

$BSX
AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength
Benzinga55d ago

AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength

$ABBV
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study
Benzinga55d ago

Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study

$PFE
FDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery Concerns
Benzinga55d ago

FDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery Concerns

$PODD
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight
GlobeNewswire Inc.55d ago

Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight

$TMO
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight
GlobeNewswire Inc.55d ago

IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight

$VRTX
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
GlobeNewswire Inc.55d ago

Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started

$LLY
Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and Carefusion
GlobeNewswire Inc.56d ago

Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and Carefusion

$RMD

Market Sentiment

Neutral

56% Sentiment Score

Sector Stats

Total Stocks1
News Today5
Avg Volume0
AI SentimentNeutral

Related Sectors

Consumer StaplesIndustrialsTechnology

© 2025 DailyFinz AI.